Babaei Omali Negar, Lada Mark, Lakkis Carol, Morgan Philip B, Nichols Jason J, Subbaraman Lakshman N, Jones Lyndon W
1Centre for Contact Lens Research, School of Optometry and Vision Science, University of Waterloo, Ontario, Canada 2Johnson and Johnson Vision Care, Inc., Jacksonville, Florida 3Eurolens Research, University of Manchester, Manchester, UK 4School of Optometry, University of Alabama, Birmingham, Alabama.
Optom Vis Sci. 2017 Sep;94(9):919-927. doi: 10.1097/OPX.0000000000001114.
There remains only a small amount of data from human studies demonstrating the effect of contact lens/lens care solution combinations on the deposition of lipids. Therefore, information on the degree to which modern materials deposit lipids when used with contemporary care solutions would be valuable.
The present study aims to determine the effect of lens care system combinations on levels of total lipid, cholesterol, and cholesteryl esters extracted from three different contact lenses (CLs) when used with four contemporary care systems.
Experienced CL wearers were recruited to participate in this study. Combinations of three CLs (etafilcon A [ETA], galyfilcon A [GALY], and senofilcon A [SENO]) and four CL care solutions (Biotrue, ClearCare, OPTI-FREE PureMoist, and RevitaLens Ocutec) were investigated. A total of 791 CLs were analyzed. Subjects were randomized to one lens type and then used all four lens care solutions in random sequence for 10-14 days before the CLs were collected and analyzed for the amount of cholesterol, cholesteryl esters, and total lipids.
The mean range of cholesterol recovered across the different care solutions was 0.34-2.77 μg/lens, 3.48-4.29 μg/lens, and 4.75-6.20 μg/lens for ETA, SENO, and GALY lenses, respectively. Use of OPTI-FREE PureMoist with ETA lenses led to a significantly greater amount of cholesterol being recovered when compared to the use of the other solutions with ETA lenses (P < .05). The mean range of cholesteryl esters recovered across different care solutions was 1.31-2.02 μg/lens, 6.43-7.19 μg/lens, and 7.96-10.13 μg/lens for ETA, SENO, and GALY lenses, respectively. There were no differences in the amount of cholesteryl esters and total lipids extracted for a given lens type when used with any of the four care solutions (P > .05).
This study did not demonstrate conclusively that any of the solution/CL combinations were superior to any of the other combinations when the amounts of lipid deposition were compared among the tested lenses.
来自人体研究的、证明隐形眼镜/护理液组合对脂质沉积影响的数据仍然很少。因此,关于现代材料与当代护理液一起使用时脂质沉积程度的信息将很有价值。
本研究旨在确定当三种不同的隐形眼镜(CL)与四种当代护理系统一起使用时,护理系统组合对从这些隐形眼镜中提取的总脂质、胆固醇和胆固醇酯水平的影响。
招募有经验的隐形眼镜佩戴者参与本研究。研究了三种隐形眼镜(依他氟康A [ETA]、加丽氟康A [GALY] 和 senofilcon A [SENO])与四种隐形眼镜护理液(倍明视、清润护理液、傲滴恒润、瑞眸睛采)的组合。共分析了791副隐形眼镜。受试者被随机分配到一种镜片类型,然后在随机顺序下使用所有四种护理液10 - 14天,之后收集隐形眼镜并分析胆固醇、胆固醇酯和总脂质的含量。
对于ETA、SENO和GALY镜片,不同护理液中回收的胆固醇平均范围分别为0.34 - 2.77μg/镜片、3.48 - 4.29μg/镜片和4.75 - 6.20μg/镜片。与ETA镜片使用其他护理液相比,ETA镜片使用傲滴恒润时回收的胆固醇量显著更高(P < 0.05)。不同护理液中回收的胆固醇酯平均范围分别为:ETA镜片为1.31 - 2.02μg/镜片、SENO镜片为6.43 - 7.19μg/镜片、GALY镜片为7.96 - 10.13μg/镜片。当给定镜片类型与四种护理液中的任何一种一起使用时,所提取的胆固醇酯和总脂质的量没有差异(P > 0.05)。
当在测试镜片之间比较脂质沉积量时,本研究没有确凿地证明任何一种护理液/隐形眼镜组合优于其他任何组合。